AIMS: previous studies have established an association between exercise intolerance and increased morbidity and mortality in congenital heart disease patients. We aimed to clarify if exercise intolerance is associated with poor outcome in Fontan patients and to identify risk factors for mortality, transplantation, and cardiac-related hospitalization. METHODS AND RESULTS: a total of 321 Fontan patients (57% male, mean age 20.9 ± 8.6 years) who underwent cardiopulmonary exercise testing (CPET) at four major European centres between 1997 and 2008 were included. During a median follow-up of 21 months, 22 patients died and 6 patients underwent cardiac transplantation (8.7%), resulting in an estimated 5-year transplant-free survival of 86%. Parameters of CPET were strongly related to increased risk of hospitalization, but-with the exception of heart rate reserve-unrelated to risk of death or transplantation. In contrast, patients with clinically relevant arrhythmia had a 6.0-fold increased risk of death or transplantation (P < 0.001). Furthermore, patients with atriopulmonary/-ventricular Fontan had a 3.7-fold increased risk of death or transplantation compared with total cavopulmonary connection patients (P= 0.009). The combination of clinically relevant arrhythmia, atriopulmonary/-ventricular Fontan, and signs of symptomatic or decompensated heart failure was associated with a particularly poor outcome (3-year mortality 25%). CONCLUSION: on short-term follow-up, most parameters of CPET are associated with increased risk of hospitalization but not death or transplantation in contemporary Fontan patients. Only decreased heart rate reserve and a history of clinically relevant arrhythmia, atriopulmonary/-ventricular Fontan, and/or heart failure requiring diuretic therapy are associated with poor prognosis, potentially identifying patients requiring medical and/or surgical attention.
AIMS: previous studies have established an association between exercise intolerance and increased morbidity and mortality in congenital heart diseasepatients. We aimed to clarify if exercise intolerance is associated with poor outcome in Fontan patients and to identify risk factors for mortality, transplantation, and cardiac-related hospitalization. METHODS AND RESULTS: a total of 321 Fontan patients (57% male, mean age 20.9 ± 8.6 years) who underwent cardiopulmonary exercise testing (CPET) at four major European centres between 1997 and 2008 were included. During a median follow-up of 21 months, 22 patients died and 6 patients underwent cardiac transplantation (8.7%), resulting in an estimated 5-year transplant-free survival of 86%. Parameters of CPET were strongly related to increased risk of hospitalization, but-with the exception of heart rate reserve-unrelated to risk of death or transplantation. In contrast, patients with clinically relevant arrhythmia had a 6.0-fold increased risk of death or transplantation (P < 0.001). Furthermore, patients with atriopulmonary/-ventricular Fontan had a 3.7-fold increased risk of death or transplantation compared with total cavopulmonary connection patients (P= 0.009). The combination of clinically relevant arrhythmia, atriopulmonary/-ventricular Fontan, and signs of symptomatic or decompensated heart failure was associated with a particularly poor outcome (3-year mortality 25%). CONCLUSION: on short-term follow-up, most parameters of CPET are associated with increased risk of hospitalization but not death or transplantation in contemporary Fontan patients. Only decreased heart rate reserve and a history of clinically relevant arrhythmia, atriopulmonary/-ventricular Fontan, and/or heart failure requiring diuretic therapy are associated with poor prognosis, potentially identifying patients requiring medical and/or surgical attention.
Authors: Ethan Kung; James C Perry; Christopher Davis; Francesco Migliavacca; Giancarlo Pennati; Alessandro Giardini; Tain-Yen Hsia; Alison Marsden Journal: Ann Biomed Eng Date: 2014-09-27 Impact factor: 3.934
Authors: Jonathan N Menachem; Nosheen Reza; Jeremy A Mazurek; Danielle Burstein; Edo Y Birati; Arieh Fox; Yuli Y Kim; Maria Molina; Sara L Partington; Monique Tanna; Lynda Tobin; Joyce Wald; Lee R Goldberg Journal: World J Pediatr Congenit Heart Surg Date: 2019-03-04
Authors: Aída L R Turquetto; Luiz F Canêo; Daniela R Agostinho; Patrícia A Oliveira; Maria Isabel C S Lopes; Patrícia F Trevizan; Frederico L A Fernandes; Maria A Binotto; Gabriela Liberato; Glaucia M P Tavares; Rodolfo A Neirotti; Marcelo B Jatene Journal: Pediatr Cardiol Date: 2017-05-12 Impact factor: 1.655
Authors: Michelle Gurvitz; Kristin M Burns; Ralph Brindis; Craig S Broberg; Curt J Daniels; Stephanie M P N Fuller; Margaret A Honein; Paul Khairy; Karen S Kuehl; Michael J Landzberg; William T Mahle; Douglas L Mann; Ariane Marelli; Jane W Newburger; Gail D Pearson; Randall C Starling; Glenn R Tringali; Anne Marie Valente; Joseph C Wu; Robert M Califf Journal: J Am Coll Cardiol Date: 2016-04-26 Impact factor: 24.094
Authors: Sean J Cooney; Kristen Campbell; Kelly Wolfe; Michael V DiMaria; Christopher M Rausch Journal: Pediatr Cardiol Date: 2020-11-15 Impact factor: 1.655
Authors: Andrew M Atz; Victor Zak; Lynn Mahony; Karen Uzark; Peter Shrader; Dianne Gallagher; Stephen M Paridon; Richard V Williams; Roger E Breitbart; Steven D Colan; Jonathan R Kaltman; Renee Margossian; Sara K Pasquali; Kerstin Allen; Wyman W Lai; Rosalind Korsin; Bradley S Marino; Nicole Mirarchi; Brian W McCrindle Journal: Congenit Heart Dis Date: 2014-06-17 Impact factor: 2.007